GRACELL BIOTECHNOLOGIES INC.
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 42.75B | ||||||
| 41.61B | ||||||
| 41.34B | - | |||||
| 26.59B | ||||||
| 25.49B |
